Magda Michna - Mar 14, 2025 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Chief Development Officer
Signature
/s/ Nathaniel Sisitsky as attorney-in-fact for Magda Michna
Stock symbol
STAA
Transactions as of
Mar 14, 2025
Transactions value $
$0
Form type
4
Date filed
3/18/2025, 06:03 PM
Previous filing
Mar 14, 2025
Next filing
May 14, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Award $0 +44K $0.00 44K Mar 14, 2025 Common Stock 44K $0.00 Direct F1, F2
transaction STAA Restricted Stock Units Award $0 +8.8K $0.00 8.8K Mar 14, 2025 Common Stock 8.8K $0.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F2 Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with annual equity award. These RSUs vest as to 1/3 (14,663 shares) on March 14, 2026, 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028.
F3 Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with the Reporting Person's promotion to Chief Development Officer. These RSUs vest as to 1/3 (2,932 shares) on March 14, 2026, 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028.